Southern Archipelago $(SAL)$ reported FY2025 revenue of SGD 4.0 million (18% decrease), with revenue from sterilisation services. SAL posted a FY2025 net loss of SGD 0.9 million, compared with a FY2024 net loss of SGD 0.2 million, and a FY2025 loss before income tax of SGD 0.7 million. For 2H2025, revenue was SGD 1.7 million (29% decrease) and net loss was SGD 0.4 million. Finance costs in FY2025 rose to SGD 0.4 million (56% increase). As at 31 December 2025, SAL reported cash and bank balances of SGD 0.3 million and total borrowings of SGD 8.4 million. Net asset value per ordinary share was 0.0034 cents (Group). The company said it was in breach of a bank loan covenant requiring minimum Group net tangible assets of SGD 2.0 million, with Group NTA at about SGD 0.9 million; the bank has verbally indicated willingness to accommodate the technical breach subject to internal review by April 2026. SAL said the sterilisation business completed an expansion of capacity in 2026 and management expects it to improve and continue generating positive operating cash flow in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Southern Archipelago Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: KLKB5FOWBTAZDNN5) on February 25, 2026, and is solely responsible for the information contained therein.